Skip to content

Biogen BIIB Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin301.9%-0.3pp302.3%-2.4pp304.7%-5.4pp310%-22.7pp
Net margin59.9%+2.2pp57.7%-26.4pp84.1%-6.2pp90.4%+22.0pp
Returns
Return on equity35.3%-1.2pp36.5%-27.7pp64.2%-17.0pp81.2%+8.9pp
Return on invested capital32%+0.6pp31.3%-20.8pp52.2%-12.9pp65.1%-1.0pp
Efficiency
Asset turnover1.4×0.0×1.4×-0.1×1.6×-0.2×1.7×-0.1×
Liquidity
Current ratio9.3×+2.3×-3.2×10.2×+0.8×9.4×+1.6×
Leverage
Debt-to-equity1.4×-0.2×1.6×-0.4×1.9×-0.2×2.2×-0.6×
Net debt / EBITDA4.6×-3.2×7.8×+0.5×7.3×+3.3×-2.9×
Per Share
Book value per share$483.91+10.1%$439.72+11.0%$396.12+17.4%$337.37+18.5%
Valuation
Market capitalization$84.89B-26.6%$115.61B-25.9%$156.12B+12.0%$139.44B-17.4%
Price / earnings57.6×-29.5×87.1×+1.1×86.1×+23.6×62.5×-27.2×
Price / sales8.5×-3.4×12×-3.7×15.6×+2.3×13.3×-1.2×
Price / book4.8×-2.5×7.2×-3.6×10.9×-0.4×11.3×-4.5×
EV / EBITDA36.1×-21.7×57.8×-5.2×63×+23.5×39.5×-19.5×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Biogen's profit margins?
Biogen (BIIB) runs a 75.5% gross margin and a 22.9% operating margin, with a 14.3% net margin.
Where do Biogen's ratios come from?
Every ratio is computed from Biogen's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.